Immune System News -- ScienceDaily Researchers explore a cancer immunotherapy treatment that involves activating the immune cells in the body and reprogramming them to attack and destroy cancer cells. This therapeutic method frequently uses cytokines, small protein molecules that act as…
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
Researchers have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.
A new study shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other, sometimes ‘unintuitive,’ revelations of how factors like age, sex and comorbidities do and don’t affect immune res…
The annual influenza vaccine has become less effective on average over time. One reason may be reduced vaccine efficacy in people with obesity than those with a healthier body mass index (BMI), while the number of people with high BMI grows. Findings s…
Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.
New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells outside the body before reinfusing them, can successfully treat this rare and aggressi…
Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
Cortisone and other related glucocorticoids are extremely effective at curbing excessive immune reactions. But previously, astonishingly little was known about how they exactly do that. Researchers have now explored the molecular mechanism of action in…
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infection.
